Healthcare & Life Sciences
Stoke Therapeutics
United Stateswww.stoketx.com
Stoke Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Stoke Therapeutics
Stoke Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Stoke Therapeutics is a clinical-stage biotechnology company developing genetic medicines that upregulate protein production by modulating RNA splicing using antisense oligonucleotides (its TANGO platform) to treat rare genetic diseases.
Explore Stoke Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.